The serum amyloid A response to sterile silver nitrate in mice and its inhibition by dexamethasone and macrolide antibiotics

International Immunopharmacology

Volumn 7, Issue 12, 2007, Pages 1544-1551

  Glojnaric, Ines ^a   Cuzic, Snjezana ^a   Erakovic Haber, Vesna ^a   Parnham, Michael J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Inflammation; Macrolide antibiotics; Mice; Serum amyloid A protein; Silver nitrate

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; AZITHROMYCIN; CLARITHROMYCIN; DEXAMETHASONE; ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROLIDE; ROXITHROMYCIN; SILVER NITRATE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ACUTE-PHASE REACTION; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; AZITHROMYCIN; CELL COUNT; CLARITHROMYCIN; DEXAMETHASONE; FEMALE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTE COUNT; MACROLIDES; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; NEUTROPHILS; PLATELET COUNT; ROXITHROMYCIN; SERUM AMYLOID A PROTEIN; SILVER NITRATE; SUBCUTANEOUS FAT;

EID: 34848877241     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.07.031     Document Type: Article

References (22)

1. Berg H.F., Boulos M., Scheffer G.-J., Peeters M.F., and Kluytmans J.A.J.W. Effect of clarithromycin on inflammatory markers in patients with atherosclerosis. Clin Diagn Lab Immunol 10 (2003) 525-528
2. Bosnar M., Kelnerić Ž., Munić V., Eraković V., and Parnham M.J. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin and cethromycin. Antimicrob Agents Chemother 49 (2005) 2372-2377
3. Bouwman J.J., Visseren F.L., Bouter P.K., and Diepersloot R.J. Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and Chlamydia pneumoniae. J Lab Clin Med 144 (2004) 18-26
4. Brandwein S.R., Sipe J.D., Skinner M., and Cohen A.S. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice. J Rheumatol 12 (1985) 418-426
5. Brandwein S.R., Sipe J.D., Tatsuta E., Skinner M., and Cohen A.S. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response. J Rheumatol 11 (1984) 597-601
6. Brissette L., Young I., Narindrasorasak S., Kisilecsky R., and Deeley R. Differential induction of the serum amyloid A gene family in response to an inflammatory agent and to amyloid-enhancing factor. J Biol Chem 264 (1989) 19327-19332
7. Čulić O., Eraković V., and Parnham M.J. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 429 (2001) 209-229
8. Glojnarić I., Eraković V., and Parnham M.J. Azithromycin and clarithromycin inhibit release of serum amyloid A protein (SAA) by inflammation in mice. Inflamm Res 52 suppl 2 (2003) S136
9. Hagihara K., Nishikawa T., Isobe T., Song J., Sugamata Y., and Yoshizaki K. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun 314 (2004) 363-369
10. Jensen L.E., and Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 334 (1998) 489-503
11. Kalechman Y., Shani A., Albeck M., and Sredni B. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties. Immunopharmacology 29 (1995) 149-158
12. Komori T., Kai H., Shimoishi K., Kabu K., Nonaka A., et al. Up-regulation by clarithromycin of alpha(1)-acid glycoprotein expression in liver and primary cultured hepatocytes. Biochem Pharmacol 62 (2001) 1391-1397
13. Labro M.-T. Macrolide antibiotics: current and future uses. Expert Opinion Pharmacother 5 (2004) 541-550
14. Mattoes H.M., and Nightingale C.H. Macrolide antibiotics. In: Schönfeld W., and Kirst H.A. (Eds). Pharmacokinetics/Pharmacodynamics (2002), Birkhäuser Verlag, Basel 25-36
15. Parnham M.J. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr Opinion Infect Dis 18 (2005) 125-131
16. Parnham M.J., Čulić O., Eraković V., Munić V., Popović-Grle S., et al. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. Eur J Pharmacol 517 (2005) 132-143
17. Pasquale T.R., and Tan J.S. Nonantimicrobial effects of antibacterial agents. Clin Infect Dis 40 (2005) 127-135
18. Rubin B.K., and Tamaoki J. Antibiotics as anti-inflammatory and immunomodulatory agents (2005), Birkhäuser Verlag, Basel
19. Tamaoki J., Kadota J., and Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 117 (2004) 5S-11S
20. Tsai W.C., Rodriguez M.L., Young K.S., Deng J.C., Thannical V.J., et al. Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 170 (2004) 1331-1339
21. Uhlar C.M., and Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265 (1999) 501-523
22. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 37 (1999) 381-388